ArticleJournal of hematology & oncology2014

A novel anti-CD19 monoclonal antibody (GBR 401) with high killing activity against B cell malignancies.

Caroline S Breton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.